Since the results so far suggest that the cytokine profiles produced by topo I-reactive CD27+ B cells differ according to their affinity for topo I, we examined the relationship of their affinity for topo I with the disease severity in anti-topo I antibody-positive SSc patients (n = 30; Figure 5). The gene discussed is CD27; the disease is systemic sclerosis.